Frailty in Children With Cardiac Disease

NCT ID: NCT02999438

Last Updated: 2023-07-14

Basic Information

• Recruitment Status: COMPLETED
• Total Enrollment: 56 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2016-11-30
• Study Completion Date: 2022-10-31

Brief Summary

Frailty is a complex biologic syndrome of diminished physiologic reserve that leads to decreased resistance to stressors and is associated with adverse health outcomes. The syndrome has been well studied in adults and is quantified by the Fried criteria, which are comprised of five components- slowness, weakness, self-reported exhaustion, shrinkage and diminished physical activity. The concept of frailty is novel in children. A study in young adult childhood cancer survivors demonstrated increased incidence of frailty in this population along with increased risk of morbidity and mortality. This suggests that frailty as a phenotype has relevance outside of the geriatric age group. Pediatric patients with single ventricle physiology, heart failure and pulmonary artery hypertension- all represent populations with significantly increased risk of mortality, morbidity and decreased quality of life. Currently, such patients are monitored outpatient by serial echocardiograms and blood work that only gives information about end organ damage. But there is no validated tool available to measure global infirmity in such children. Better understanding of the relevance and applicability of frailty in pediatrics may allow for identification of the most vulnerable pediatric cardiac patients and be of value in optimizing their clinical management and improving health outcomes.

Conditions

Pulmonary Hypertension; Heart Failure; Single Ventricle

Study Design

• Observational Model Type: CASE_CONTROL
• Study Time Perspective: CROSS_SECTIONAL

Study Groups

Patients with hemodynamically significant heart disease

Patients with either:

1. Single ventricle physiology s/p Fontan

2. Heart failure diagnosed by a cardiologist

3. Pulmonary hypertension diagnosed by cath

Actigraph to check activity levels at home

Intervention Type: DEVICE

Controls

Healthy controls as defined in inclusion- exclusion criteria

Actigraph to check activity levels at home

Intervention Type: DEVICE

Interventions

Actigraph to check activity levels at home

Intervention Type: DEVICE

Eligibility Criteria

Inclusion Criteria

SUBJECT/CASE POPULATION herein referred to as Subjects:

• Children and adolescents between the ages of 8.0-17.50 years
• Subjects must be diagnosed with one of the following heart conditions:

• Subjects with single ventricle physiology and Fontan surgery completion at least 6 months prior to study enrollment
• Subjects with diagnosis of heart failure by a cardiologist
• Subjects with a diagnosis of pulmonary arterial hypertension, confirmed by cardiac catheterization, requiring use of at least 1 pulmonary vasodilator or oxygen for their pulmonary hypertension

CONTROL POPULATION herein referred to as Controls:

• Healthy children and adolescents between the ages of 8.0-17.50 years

Exclusion Criteria

BOTH SUBJECT/CASE POPULATION AND CONTROL POPULATION:

• Subjects or controls with known severe neurological or respiratory diseases, eating disorders (such as anorexia, bulimia) or physical limitations (wheelchair bound) which may impact their ability to perform study procedures in the opinion of the provider.
• Subjects or controls with tracheostomy and ventilator dependency
• Subjects or controls with unstable angina/ myocardial infarction in the last 4 weeks
• Subjects or controls who are unable to perform 6 continuous minutes of walking, hand-grip dynamometry, or complete questionnaire measures as described.

SUBJECT/ CASE POPULATION:

• Subjects with heart transplantation within the past 1 year
• Subject will be excluded if the cardiologist feels that the study is not appropriate for the subject.

CONTROL POPULATION:

• Controls with any known chronic medical condition requiring some medication over the past 30 days.
• Controls on any chronic prescription medicines for > 30 days

• Minimum Eligible Age: 8 Years
• Maximum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

Children's Mercy Hospital Kansas City

OTHER

Sponsor Role: lead

Responsible Party

Brian Birnbaum

Physician, Associate Professor of Pediatrics

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Brian Birnbaum, MD

Role: PRINCIPAL_INVESTIGATOR

Children's Mercy Hospital Kansas City

Locations

Children's Mercy Hospital

Kansas City, Missouri, United States

Countries

United States

References

Panchangam C, White DA, Goudar S, Birnbaum B, Malloy-Walton L, Gross-Toalson J, Reid KJ, Shirali G, Parthiban A. Translation of the Frailty Paradigm from Older Adults to Children with Cardiac Disease. Pediatr Cardiol. 2020 Jun;41(5):1031-1041. doi: 10.1007/s00246-020-02354-7. Epub 2020 May 6.

Reference Type: DERIVED

PMID: 32377892 (View on PubMed)

Other Identifiers

16060468

Identifier Type: -

Identifier Source: org_study_id